Non-invasive MRI biomarkers for assessment of neoadjuvant chemotherapy response in osteosarcoma: Current techniques and clinical perspectives | Synapse
March 3, 2026Open Access
Non-invasive MRI biomarkers for assessment of neoadjuvant chemotherapy response in osteosarcoma: Current techniques and clinical perspectives
Key Points
Non-invasive MRI biomarkers enhance evaluation of tumor response during neoadjuvant chemotherapy in osteosarcoma.
The incorporation of MRI innovations may improve treatment personalization through better response monitoring.
Assessment involved a variety of current MRI techniques across multiple clinical settings for osteosarcoma.
Challenges in standardization and inter-observer variability highlight the need for more consensus in clinical practice.